chapter 1 James Parkinson -- chapter 2 Paralysis Agitans�Refining the Diagnosis and Treatment -- chapter 3 The Role of Dopamine in Parkinson's Disease: A Historical Review -- chapter 4 Parkinson's Disease: Where Are We? -- chapter 5 Epidemiology of Parkinson's Disease: An Overview -- chapter 6 Environmental Toxins and Parkinson's Disease -- chapter 7 Rural Environment and Parkinson's Disease -- chapter 8 Industrial and Occupational Exposures and Parkinson's Disease -- chapter 9 Tetrahydroisoquinolines and Parkinson's Disease -- chapter 10 Xenobiotic Metabolism and Idiopathic Parkinson's Disease -- chapter 11 Progressive Neurodegeneration in the Chronic MPTP/Probenecid Model of Parkinson's Disease -- chapter 12 Alpha-Synuclein and Parkinson's Disease -- chapter 13 Parkin and Its Role in Parkinson's Disease -- chapter 14 Heredofamilial Parkinsonism -- chapter 15 Other Mutations: Their Role in Parkinson's Disease -- chapter 16 Classical Motor Features of Parkinson's Disease -- chapter 17 Clinical Evaluation and Treatment of Gait Disorders in Parkinson's Disease -- chapter 18 Sensory Symptoms and Sensorimotor Distortion in Parkinson's Disease -- chapter 19 Pain in Parkinson's Disease -- chapter 20 Fatigue: A Common Comorbidity in Parkinson's Disease -- chapter 21 Sleep Disorders in Parkinson's Disease -- chapter 22 Visual Function in Parkinson's Disease -- chapter 23 Visuocognitive Dysfunctions in Parkinson's Disease -- chapter 24 Olfactory Dysfunction in Parkinson's Disease and Parkinsonian Syndromes -- chapter 25 Gastrointestinal Dysfunction in Parkinson's Disease -- chapter 26 Urinary Dysfunction in Parkinson's Disease -- chapter 27 Sexual Dysfunction -- chapter 28 Cardiovascular Autonomic Dysfunction in Parkinson's Disease and Parkinsonian Syndromes -- chapter 29 Disorders of Thermoregulation in Parkinson's Disease -- chapter 30 Respiratory Dysfunction -- chapter 31 Depression in Parkinson's Disease -- chapter 32 Anxiety and Parkinson's Disease -- chapter 33 Dementia in Parkinson's Disease -- chapter 34 Animal Models of Basal Ganglia Injury and Degeneration and Their Application to Parkinson's Disease Research -- chapter 35 The Neuropathology of Parkinson's Disease and Other Parkinsonian Disorders -- chapter 36 Pathophysiology of the Motor Disorder -- chapter 37 MPTP Disrupts Dopamine Receptors and Dopamine Transporters -- chapter 38 Pathophysiology of Parkinson's Disease, Neurochemical Pathology: Other Neurotransmitters. -- chapter 39 Metallothionein Isoforms Attenuate Peroxynitrite-Induced Oxidative Stress in Parkinson's Disease -- chapter 40 Excitotoxicity in Parkinson's Disease -- chapter 41 Inflammation -- chapter 42 Cell Death in Parkinson's Disease -- chapter 43 Weaver Mutant Mouse in Progression of Neurodegeneration in Parkinson's Disease -- chapter 44 Differential Diagnosis of Parkinson's Disease -- chapter 45 Diagnostic Criteria for Parkinson's Disease -- chapter 46 Neuroleptic-Induced Movement Disorders -- chapter 47 The Placebo Effect in Parkinson's Disease -- chapter 48 Dopamine Transporter Imaging Using SPECT in Parkinson's Disease -- chapter 49 MR Imaging of Parkinsonism -- chapter 50 Clinical Batteries -- chapter 51 Rating Scales -- chapter 52 Treatment of Parkinson's Disease with Anticholinergic Medications -- chapter 53 Amantadine -- chapter 54 The Role of MAO-B Inhibitors in the Treatment of Parkinson's Disease -- chapter 55 Catechol-O-Methyltransferase Inhibitors in the Treatment of Parkinson's Disease -- chapter 56 Symptomatic Treatment of Parkinson's Disease: Levodopa -- chapter 57 Dopamine Agonists in Parkinson's Disease -- chapter 58 Parkinson's Disease: Surgical Treatment-Stereotactic Procedures -- chapter 59 Neurotransplantation in Parkinson's Disease -- chapter 60 The Role of Physical Therapy in Management of Parkinson's Disease -- chapter 61 Swallowing Function in Parkinson's Disease -- chapter 62 Restorative and Psychosocial Occupational Therapy in Parkinson's Disease -- chapter 63 Music Therapy for People with Parkinson's -- chapter 64 Pathogenesis of Motor Response Complications in Parkinson's Disease: Mere Conjectural Suggestions and Beyond -- chapter 65 Treatment of Early Parkinson's Disease -- chapter 66 Moderate Parkinson's Disease -- chapter 67 Management of Advanced Parkinson's Disease -- chapter 68 Future Symptomatic Therapy in Parkinson's Disease -- chapter 69 Restorative Therapy in Parkinson's Disease -- chapter 70 Gene Therapy for Parkinson's Disease -- chapter 71 Translating Stem Cell Biology to Regenerative Medicine for Parkinson's Disease -- chapter 72 Alternative Drug Delivery in the Treatment of Parkinson's Disease -- chapter 73 The Role and Designs of Clinical Trials for Parkinson's Disease -- chapter 74 Positron Emission Tomography in Parkinson's Disease -- chapter 75 Economics of Parkinson's Disease -- chapter 76 Informal Caregivers: A Valuable Part of the Health Care Team -- chapter 77 Quality of Life in Parkinson's Disease: A Conceptual Model -- chapter 78 The Evolution and Potential of the National Parkinson Organizations: A Brief Overview.